Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates
Issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease. Jackson Center, PA, May 28, 2025 – Halberd Corporation (OTC "HALB”) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation ...